USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Nisshin Pharma Inc.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C11B (PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

14.6

Avg claims per patent

+150%

5-year filing velocity

The verdict

Nisshin holds 7 US patents across 10 technology areas, rank #36,633 of 50,000 tracked assignees.

#36,633
of 50,000 US assignees by volume: Top 70%
by Innovation Score (29.3/100): 14.6
avg claims per patent: +150%
filing velocity, last 5 yrs

Portfolio overview

Nisshin Pharma Inc. has been granted 7 US utility patents between 2016 and 2025, placing Nisshin Pharma Inc. at rank #36,633 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.6 claims per patent with primary concentration in C11B (PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES). As a Foreign Corporation, Nisshin Pharma Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Nisshin sits between Ningbo Xuanhua Electric Co., Ltd. (7 patents, rank #36,629) and NLB, Corp. (7 patents, rank #36,637) - the closest US assignees by grant volume. The composite Innovation Score of 29.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 2 in the 2015–2019 window, a +150% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Nisshin Pharma Inc.'s 14.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nisshin Pharma Inc. against peers pursuing similar technology classes.

Ningbo Xuanhua El…

7
Nippon OIL

7
Niramai Health An…

7
Nishina Industrial

7
Nitricgen

7
Nitto Belgium

7
Nitto Kasei

7
NLB

7
Nisshin Pharma ◀

7

What this shows Nisshin holds 7 patents at rank #36,633, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Nisshin

By rank, the assignees closest to #36,633 in granted patent volume.

Leaders in C11B (Producing)

Other assignees with the most granted patents in Nisshin's primary technology class.

Nisshin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

29 Top 70% higher than 30% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Nisshin Pharma Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	28.6%
2020	2	28.6%
2021	1	14.3%
2023	1	14.3%
2025	1	14.3%

Which technologies does Nisshin Pharma Inc. patent most?

C11B - PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES 5

C11C - FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM 4

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 4

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 2

A23L - FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF 2

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 1

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 1

C12Y - ENZYMES 1

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 1

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#36,633

Across all tracked assignees

Innovation Score

29.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Nisshin Pharma Inc. hold?

Nisshin Pharma Inc. holds 7 US granted patents filed between 2016 and 2025, spanning 10 technology areas.

What is Nisshin Pharma Inc.'s Innovation Score?

Nisshin Pharma Inc. has an Innovation Score of 29.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Nisshin Pharma Inc. focus on?

Nisshin Pharma Inc.'s top technology area is C11B (PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES) with 5 patents. The company has filed patents in 10 CPC subclasses total.

Is Nisshin Pharma Inc.'s patent filing rate increasing or decreasing?

Nisshin Pharma Inc.'s recent filing velocity is +150% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Nisshin Pharma Inc.'s patents?

Nisshin Pharma Inc.'s patents average 14.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Nisshin Pharma Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Nisshin's 7 grants land it in the top 70% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Nisshin ranks #36,633 of 50,000. Top 50 holders
Most of this portfolio concentrates in C11B - see who else leads that technology area. C11B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.